Transplacental treatment of foetal supraventricular tachycardia with triple antiarrhythmic combination to avoid intra-foetal intervention

BABAOĞLU A., DOĞAN Y., Uzun O.

CARDIOLOGY IN THE YOUNG, cilt.32, sa.7, ss.1162-1165, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 7
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1017/s1047951121004595
  • Dergi Adı: CARDIOLOGY IN THE YOUNG
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Agricultural & Environmental Science Database, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.1162-1165
  • Anahtar Kelimeler: Supraventricular tachycardia, foetal, triple combination, therapy, FLECAINIDE, MANAGEMENT, DIGOXIN, SOTALOL
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Although a high percentage of foetuses with supraventricular tachycardia respond to single or dual antiarrhythmic therapy, on occasion when there is no response to these combination regimens, direct intra-foetal therapy remains the only choice, albeit such an approach carries a potential risk to the foetus. Data with regard to the safety and efficacy of triple antiarrhythmic combination have not been reported before. Here, we present a foetus with intractable tachycardia in whom arrhythmia termination was successfully achieved with triple oral antiarrhythmic therapy.